Bringing doctors together

or

A free, private network for verified physicians

Leading voices

Dr. Mark Clapp

MFM · MGH

View

Dr. Kirat Sandhu

MFM · UH

View

Dr. Malavika Prabhu

MFM · MGH

View

Dr. Katherine Bligard

MFM · WUSTL

View

Dr. Ilina Pluym

MFM · UCLA

View

Dr. Andrew Rausch

MFM · UCMC

View

Dr. Karen Gibbins

MFM · OHSU Hospital

View

Dr. Susan Khalil

MIGS · ISMMS

View

Dr. Tori O’Daniel

OB Hospitalist · Laborie-MCH division, Senior Medical Director

View

Dr. Alissa Erogbogbo

OB Hospitalist · Washington Health System

View
  • Discover your community

  • Stay current

  • A profile that represents you

  • Find your people

About RoonPrivacyTerms

    Overview

    Glecaprevir/Pibrentasvir Concentrations in the Breastmilk of Lactating Women.

    Sep 25, 2026DOI: 10.1093/cid/ciag503Journal ArticleCID

    Written by: L Madeline McCraryHideji FujiwaraJohn RobinsonJeannie KellyMegan R CurtisMichael J DurkinTracey Habrock-BachJeffrey P HendersonLaura R Marks

    Find these authors on Roon

    MM

    Dr. Madeline McCrary

    General ID · WUSTL

    JK

    Dr. Jeannie Kelly

    MFM · WUSTL

    Summary

    In this prospective pharmacokinetic study of women undergoing chronic hepatitis C virus treatment with glecaprevir/pibrentasvir, the mean glecaprevir and pibrentasvir concentrations in breastmilk were 0.63% and 4.23% of maternal plasma concentrations, with a mean relative infant dose of 0.02% and 0.06%, respectively.
    JKDr. Jeannie Kelly
    Leading Voice

    Dr. Jeannie Kelly

    Obstetrics & Gynecology (OBGYN) · Maternal Fetal Medicine (MFM)
    Washington University in St. Louis
    drjeanniekelly
    St. Louis, MO